\-\ Texto\\:\\ \ \(0\)\
\-\ \\*markedly\\ ataxic\\ gait\\.\\ \\ \ \(0\)\
\-\ \\*abnormal\\ mini\\-mental\\ status\\ exam\\ score\\ of\\ 22\\/30\\.\ \(0\)\
\-\ the\\ patient\\ underwent\\ csf\\ shunting\\,\\ which\\ resulted\\ in\\ a\\ mild\\ improvement\\ in\\ symptoms\\.\ \(0\)\
\-\ axial\\ ct\\ images\\ through\\ the\\ brain\\ show\\ communicating\\ hydrocephalus\\,\\ with\\ dilatation\\ of\\ the\\ third\\ ventricle\\ and\\ lateral\\ ventricles\\ in\\ the\\ absence\\ of\\ significant\\ co\\-existent\\ sulcal\\ enlargement\\.\\ \\ also\\ noted\\ were\\ prominent\\ temporal\\ horns\\ \\(not\\ shown\\)\\.\ \(0\)\
\-\ normal\\ pressure\\ hydrocephalus\\ \\(nph\\)\ \(0\)\
\-\ a\\ normal\\ opening\\ pressure\\ at\\ lumbar\\ puncture\\,\\ in\\ combination\\ with\\ the\\ previously\\ described\\ imaging\\ findings\\,\\ confirmed\\ the\\ diagnosis\\ of\\ normal\\ pressure\\ hydrocephalus\\.\ \(0\)\
\-\ a\\ 76\\-year\\-old\\ african\\ american\\ male\\ with\\ end\\ stage\\ renal\\ disease\\,\\ hypertension\\,\\ hyperlipidemia\\,\\ and\\ hypothyroidism\\,\\ now\\ presenting\\ with\\ a\\ 2\\-3\\ month\\ history\\ of\\ mental\\ status\\ changes\\,\\ ataxia\\,\\ and\\ urinary\\ incontinence\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ hydrocephalus\\:\\ 0\\.28721694466235376\ \(0\)\
\-\ pressure\\:\\ 0\\.26789801234951427\ \(0\)\
\-\ mental\\:\\ 0\\.20442521535225128\ \(0\)\
\-\ nph\\:\\ 0\\.168718389786749\ \(0\)\
\-\ status\\:\\ 0\\.1636911756376765\ \(0\)\
\-\ ataxic\\:\\ 0\\.15446742537470473\ \(0\)\
\-\ sulcal\\:\\ 0\\.14480424678613746\ \(0\)\
\-\ normal\\:\\ 0\\.14365459302749325\ \(0\)\
\-\ the\\:\\ 0\\.14041032246160903\ \(0\)\
\-\ score\\:\\ 0\\.13329866052400577\ \(0\)\
\-\ shunting\\:\\ 0\\.13188018118250283\ \(0\)\
\-\ horns\\:\\ 0\\.1305532823740932\ \(0\)\
\-\ hyperlipidemia\\:\\ 0\\.12871087470052875\ \(0\)\
\-\ opening\\:\\ 0\\.12813168722582222\ \(0\)\
\-\ puncture\\:\\ 0\\.12813168722582222\ \(0\)\
\-\ communicating\\:\\ 0\\.12496238074384815\ \(0\)\
\-\ incontinence\\:\\ 0\\.12400593872712516\ \(0\)\
\-\ hypothyroidism\\:\\ 0\\.12221700259393556\ \(0\)\
\-\ resulted\\:\\ 0\\.11941815290364816\ \(0\)\
\-\ in\\:\\ 0\\.11670238371706991\ \(0\)\
\-\ of\\:\\ 0\\.11475642784718773\ \(0\)\
\-\ ataxia\\:\\ 0\\.11388072281377795\ \(0\)\
\-\ combination\\:\\ 0\\.10884105515878015\ \(0\)\
\-\ african\\:\\ 0\\.10592874946926967\ \(0\)\
\-\ markedly\\:\\ 0\\.10355030186188235\ \(0\)\
\-\ end\\:\\ 0\\.10320763066811288\ \(0\)\
\-\ ventricles\\:\\ 0\\.1030384132874794\ \(0\)\
\-\ improvement\\:\\ 0\\.10237513655164626\ \(0\)\
\-\ gait\\:\\ 0\\.10157504354455074\ \(0\)\
\-\ urinary\\:\\ 0\\.10141869453492328\ \(0\)\
\-\ american\\:\\ 0\\.10006261219331679\ \(0\)\
\-\ dilatation\\:\\ 0\\.09573898155411792\ \(0\)\
\-\ described\\:\\ 0\\.09515651212622618\ \(0\)\
\-\ lumbar\\:\\ 0\\.09470213350732176\ \(0\)\
\-\ previously\\:\\ 0\\.09414792756143014\ \(0\)\
\-\ absence\\:\\ 0\\.09350201698566757\ \(0\)\
\-\ stage\\:\\ 0\\.09339631086240326\ \(0\)\
\-\ csf\\:\\ 0\\.09267120513370992\ \(0\)\
\-\ prominent\\:\\ 0\\.09236810683326023\ \(0\)\
\-\ presenting\\:\\ 0\\.0918726660962826\ \(0\)\
\-\ with\\:\\ 0\\.0918599958283852\ \(0\)\
\-\ shown\\:\\ 0\\.09091622407955961\ \(0\)\
\-\ temporal\\:\\ 0\\.09009189023138235\ \(0\)\
\-\ enlargement\\:\\ 0\\.08991310827279159\ \(0\)\
\-\ hypertension\\:\\ 0\\.08973586755715475\ \(0\)\
\-\ third\\:\\ 0\\.08929933744983809\ \(0\)\
\-\ confirmed\\:\\ 0\\.08647851042374859\ \(0\)\
\-\ ventricle\\:\\ 0\\.0863284382560826\ \(0\)\
\-\ underwent\\:\\ 0\\.0807910081662124\ \(0\)\
\-\ now\\:\\ 0\\.08050742028135223\ \(0\)\
\-\ show\\:\\ 0\\.07445239520226424\ \(0\)\
\-\ brain\\:\\ 0\\.07311238845864163\ \(0\)\
\-\ renal\\:\\ 0\\.07303391586076131\ \(0\)\
\-\ and\\:\\ 0\\.07270377269447613\ \(0\)\
\-\ month\\:\\ 0\\.07134311736347458\ \(0\)\
\-\ changes\\:\\ 0\\.07087947699821312\ \(0\)\
\-\ abnormal\\:\\ 0\\.0704605872143168\ \(0\)\
\-\ through\\:\\ 0\\.06981432041196543\ \(0\)\
\-\ axial\\:\\ 0\\.0677454663114916\ \(0\)\
\-\ significant\\:\\ 0\\.06771520906440422\ \(0\)\
\-\ mild\\:\\ 0\\.06648301238421378\ \(0\)\
\-\ symptoms\\:\\ 0\\.06416927630962138\ \(0\)\
\-\ noted\\:\\ 0\\.06218197870811723\ \(0\)\
\-\ imaging\\:\\ 0\\.06163490086930657\ \(0\)\
\-\ diagnosis\\:\\ 0\\.06079740862574954\ \(0\)\
\-\ were\\:\\ 0\\.060454737431980064\ \(0\)\
\-\ exam\\:\\ 0\\.05903909021331171\ \(0\)\
\-\ lateral\\:\\ 0\\.0582037639740105\ \(0\)\
\-\ findings\\:\\ 0\\.05788265820340141\ \(0\)\
\-\ also\\:\\ 0\\.05516541204741297\ \(0\)\
\-\ images\\:\\ 0\\.05425006497878153\ \(0\)\
\-\ which\\:\\ 0\\.053328635394749704\ \(0\)\
\-\ male\\:\\ 0\\.052217814814325095\ \(0\)\
\-\ disease\\:\\ 0\\.04923021070323085\ \(0\)\
\-\ not\\:\\ 0\\.04629957343202993\ \(0\)\
\-\ history\\:\\ 0\\.04480796159217908\ \(0\)\
\-\ ct\\:\\ 0\\.044649808537827504\ \(0\)\
\-\ at\\:\\ 0\\.044298350480607034\ \(0\)\
\-\ patient\\:\\ 0\\.038145477031411315\ \(0\)\
